Clinical Trials Browser

INDUSTRY × Granisetron × Tumor-Agnostic × Clear all

NCT01909856 2015-12-04

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Phase 2 Completed

Neoplasms